Maximum quantity allowed is 999
CAS RN: 9041-93-4 | Product Number: B3972
Bleomycin Sulfate (mixture)

Purity: >85.0%(HPLC)
Size | Unit Price | Same Day | 2-3 Business Days | Other Lead Time |
Shipping Information
![]() |
---|---|---|---|---|---|
10MG |
NT$6,804
|
31 | ≥80 | Contact Us | |
50MG |
NT$30,576
|
≥40 | ≥80 | Contact Us |
* The above prices include freight cost, customs, and other charges to the destination except for products that need to be shipped by sea or dry ice. For details, please contact
our distributor
in Taiwan to order our product.
* The storage conditions are subject to change without notice.
Supplemental Product Information:
This product has not been tested for potency and is guaranteed for chemical purity.
Product Number | B3972 |
Purity / Analysis Method | >85.0%(HPLC) |
Physical State (20 deg.C) | Solid |
Storage Temperature | Refrigerated (0-10°C) |
Store Under Inert Gas | Store under inert gas |
Condition to Avoid | Hygroscopic,Heat Sensitive |
Packaging and Container | 10MG-Glass Bottle with Plastic Insert (View image), 50MG-Glass Bottle with Plastic Insert (View image) |
CAS RN | 9041-93-4 |
Related CAS RN | 11056-06-7 |
PubChem Substance ID | 253659941 |
Merck Index (14) | 1318 |
MDL Number | MFCD00070310 |
Appearance | White to Light yellow powder to crystal |
Purity(HPLC) | min.85.0 area% (Sum of A2,B2) |
BleomycinA2 | 55.0 to 70.0 area% |
BleomycinB2 | 25.0 to 32.0 area% |
Pictogram |
![]() |
Signal Word | Warning |
Hazard Statements | H351 : Suspected of causing cancer. |
Precautionary Statements | P501 : Dispose of contents/ container to an approved waste disposal plant. P202 : Do not handle until all safety precautions have been read and understood. P201 : Obtain special instructions before use. P280 : Wear protective gloves/ protective clothing/ eye protection/ face protection. P308 + P313 : IF exposed or concerned: Get medical advice/ attention. P405 : Store locked up. |
RTECS# | EC5991990 |
H.S.code* | 2941.90-000 |
Reference
- The Role of Drug Repurposing in the Development of Novel Antimicrobial Drugs: Non-Antibiotic Pharmacological Agents as Quorum Sensing-Inhibitors
References
- 1) Identification and validation of small molecules that enhance recombinant adeno-associated virus transduction following high-throughput screens
References
- Effect of lecithinized-superoxide dismutase on the interstitial pneumonia model induced by bleomycin in mice
- Regulation of type II alveolar epithelial cell proliferation by TGF-beta during bleomycin-induced lung injury in rats
- Production of superoxide and nitric oxide by alveolar macrophages in the bleomycin-induced interstitial pneumonia mice model
- Dual effect of AMD3100, a CXCR4 antagonist, on bleomycin-induced lung inflammation
- Pharmacologic differentiation of inflammation and fibrosis in the rat bleomycin model
- In vivo antioxidant treatment protects against bleomycin-induced lung damage in rats
- Effects of phosphodiesterase 4 inhibition on bleomycin-induced pulmonary fibrosis in mice
References
- Modeling pulmonary fibrosis with bleomycin
- Pulmonary fibrosis: searching for model answers
References
- Mechanisms of bleomycin-induced DNA degradation (a review)
- Cleavage of Nucleic Acids by Bleomycin (a review)
- Bleomycin: New Perspectives on the Mechanism of Action (a review)
- Antitumor Antibiotics: Bleomycin, Enediynes, and Mitomycin (a review)
- Direct Hydrogen-Atom Abstraction by Activated Bleomycin: An Experimental and Computational Study
Articles/Brochures
Safety Data Sheet (SDS)
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Sample C of A
A sample C of A for this product is not available at this time.
Analytical Charts
The requested analytical chart is not available. Sorry for the inconvenience.